Incidence and risk factors of central nervous system relapse in histologically aggressive non-Hodgkin's lymphoma uniformly treated and receiving intrathecal central nervous system prophylaxis: A GELA study on 974 patients
- 1 June 2000
- journal article
- Published by Elsevier in Annals of Oncology
- Vol. 11 (6) , 685-690
- https://doi.org/10.1023/a:1008394827806
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Isolated Central Nervous System Relapse in Aggressive Non-Hodgkin's Lymphoma: the Bologna ExperienceLeukemia & Lymphoma, 1999
- Central Nervous System Relapse in Non-Hodgkin LymphomaArchives of Neurology, 1997
- Central Nervous System Involvement in Patients with Diffuse Aggressive Non-Hodgkinʼs LymphomaAmerican Journal of Clinical Oncology, 1991
- Secondary central nervous system involvement by non‐Hodgkin's lymphoma: The risk factorsHematological Oncology, 1990
- Central nervous system metastases from non-hodgkin's lymphoma: Treatment and prophylaxisThe American Journal of Medicine, 1988
- Central nervous system involvement in non-Hodgkin's lymphoma: An analysis of 105 casesCancer, 1982
- Central nervous system relapse in malignant lymphomas: risk factors and implications for prophylaxisBlood, 1979
- Central nervous system complications of non-Hodgkin's lymphomaThe American Journal of Medicine, 1979
- Central nervous system complications in patients with diffuse histiocytic and undifferentiated lymphoma: leukemia revisitedBlood, 1976
- Involvement of the central nervous system in non-hodgkin's lymphomaCancer, 1975